Taken together, these results suggest that Nrf2 regulates the rate of proliferation and cell cycle progression in pancreatic cancer cells exhibiting high basal levels and activity of Nrf2, such as Suit-2. This evidence concerns the gene NFE2L2 and pancreatic neoplasm.